Clinical trial
Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain
NCT00295711 · DOV Pharmaceutical, Inc., Industry · Completed
Key facts
| NCT number | NCT00295711 |
|---|---|
| Title | Efficacy and Safety of Bicifadine in the Treatment of Chronic Low Back Pain |
| Official title | A Multi-Center Double-Blind, Placebo-Controlled Randomized Study of Bicifadine 200 Mg BID, Bicifadine 300 Mg BID, and Bicifadine 400 Mg BID in the Treatment of Chronic Low Back Pain |
| Lead sponsor | DOV Pharmaceutical, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Low Back Pain |
| Intervention type | Drug |
| Interventions | Bicifadine |
| Enrollment | 532 |
| Start date | Sep 1, 2004 |
| First posted | Feb 24, 2006 |
| Last update posted | Jun 23, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: